What is SANUWAVE Health, Inc.'s market cap?

SANUWAVE Health, Inc. (SNWV) has a market capitalization of $86.0M and trades on XNAS.

What is SANUWAVE Health, Inc.'s revenue and profitability?

SANUWAVE Health, Inc. generated $44.3M in trailing twelve-month revenue with net income of $16.5M, representing a net margin of 37.2%. Gross margin stands at 76.7%, with free cash flow of $4.0M. These figures are based on the Q1 2026 filing.

Who are SANUWAVE Health, Inc.'s competitors?

SANUWAVE Health, Inc.'s key competitors include Organogenesis, Solventum, MiMedx Group, and others. These companies compete in similar markets and product categories.

Who does SANUWAVE Health, Inc. partner with?

SANUWAVE Health, Inc.'s notable partners include Nortech Systems, Inc, Dynamic Group, Centers for Medicare and Medicaid Services.

Where is SANUWAVE Health, Inc. headquartered?

SANUWAVE Health, Inc. is headquartered in United States of America. It has been publicly traded since 2008.

SANUWAVE Health, Inc.

SNWV

Sanuwave Health is a medical device company specializing in regenerative medicine and directed energy therapies for the wound care market.

Market cap

$85.99M0.0%

Revenue$44.3M+22.5%

Net income$16.5M+148%

Free cash flow$4.0M+281%

EPS (diluted)$0.38+104%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 12, 2026

Revenue$9.6MBeat by $19.0K EPS-$0.17Miss by $0.03

Read the full report

Next report

Aug 14, 2026 (in a month)

Revenue estimate$11.5M

EPS estimate-$0.03

Financials

Q1 2026

Income statement

See full

Revenue$9.6M+3.1%

Gross profit$7.4M+0.8%

Operating income-$1.1M-287%

Net income-$1.4M+76.5%

EPS (diluted)-$0.17+76.4%

Balance sheet

See full

Cash & equivalents$10.8M+26.8%

Total debt$21.7M+5,319%

Total equity$1.8M+109%

Total assets$37.1M+20.2%

Cash flow

See full

Operating cash flow$397.0K+126%

CapEx$23.0K-85.8%

Free cash flow$374.0K+122%

Valuation & ratios

Valuation

See full

Market cap$85.99M0.0%

Enterprise value$96.88M—

P/E5.2×—

P/S1.9×—

Profitability

See full

Gross margin76.7%+0.1pp

Operating margin7.3%-8.6pp

Net margin37.2%+21.6pp

FCF margin9%—

Returns & leverage

See full

Debt / equity11.8×—

Current ratio1.3×+0.9×

Segments

By product

See full

Consumables, parts, and accessories revenue$6.6M—

System revenue$2.9M-10.0%

Extended warranty$60.0K—

Other$43.0K—

License fees-—

By segment

See full

Reportable Segment$9.6M+3.1%

Competitors

By market cap

Solventum$13.4B+3.0%

IAR

Integra LifeSciences$1.4B+51.5%

MiMedx Group$573.4M-34.9%

Organogenesis Holdings Inc.$312.7M-30.4%

InfuSystem Holdings$194.8M+45.1%

The Beauty Health Company$89.7M-63.3%

SANUWAVE Health, Inc.$86.0M—

Profusa, Inc. Common Stock$542.9K—

By revenue growth

SANUWAVE Health, Inc.+22.5%

Organogenesis Holdings Inc.+12.2%

MiMedx Group+10.5%

IAR

Integra LifeSciences+1.2%

Solventum-0.5%

The Beauty Health Company-8.2%

By net margin

SANUWAVE Health, Inc.37.2%+132pp

Solventum17.33%—

MiMedx Group7.88%—

Organogenesis Holdings Inc.0.528%—

The Beauty Health Company-2.04%+9.9pp

IAR

Integra LifeSciences-30.15%—

Profile

Sanuwave Health is a medical device company specializing in regenerative medicine and directed energy therapies for the wound care market. The company develops and markets non-invasive ultrasound technology designed to stimulate biological responses that repair and regenerate tissue, musculoskeletal, and vascular structures. Its core value proposition centers on improving patient outcomes by reducing healing times and pain through non-contact, fluid-mist energy delivery.

Competitive position

Sanuwave holds a proprietary position in non-contact, low-frequency ultrasound therapy with a significant intellectual property portfolio and established CMS Category 1 reimbursement.

GeographiesUnited States

Customer segmentsHealthcare Providers, Post-acute Care Facilities, Acute Care Hospitals

Business modelRazor-razorblade, Direct sales, Equipment manufacturing

SuppliersContract manufacturers, Electronic component suppliers, Sterile packaging providers, Specialized medical grade fluid suppliers

CustomersWound care clinics, Hospital outpatient departments, Long-term care facilities, Home health agencies

CountryUnited States of America

Listed2008

CEOMorgan C. Frank

FilingsSEC EDGAR

Ask your AI about SANUWAVE Health, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SANUWAVE Health, Inc.'s market cap?: SANUWAVE Health, Inc. (SNWV) has a market capitalization of $86.0M and trades on XNAS.
What is SANUWAVE Health, Inc.'s revenue and profitability?: SANUWAVE Health, Inc. generated $44.3M in trailing twelve-month revenue with net income of $16.5M, representing a net margin of 37.2%. Gross margin stands at 76.7%, with free cash flow of $4.0M. These figures are based on the Q1 2026 filing.
Who are SANUWAVE Health, Inc.'s competitors?: SANUWAVE Health, Inc.'s key competitors include Organogenesis, Solventum, MiMedx Group, and others. These companies compete in similar markets and product categories.
Who does SANUWAVE Health, Inc. partner with?: SANUWAVE Health, Inc.'s notable partners include Nortech Systems, Inc, Dynamic Group, Centers for Medicare and Medicaid Services.
Where is SANUWAVE Health, Inc. headquartered?: SANUWAVE Health, Inc. is headquartered in United States of America. It has been publicly traded since 2008.